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In brain development, apoptosis is a physiolog-
ical process that controls the final numbers
of neurons. Here, we report that the activity-
dependent prevention of apoptosis in juvenile
neurons is regulated by kinesin superfamily
protein 4 (KIF4), amicrotubule-basedmolecular
motor. The C-terminal domain of KIF4 is a mod-
ule that suppresses the activity of poly (ADP-
ribose) polymerase-1 (PARP-1), a nuclear en-
zyme known to maintain cell homeostasis by
repairing DNA and serving as a transcriptional
regulator. When neurons are stimulated by
membrane depolarization, calcium signaling
mediated by CaMKII induces dissociation of
KIF4 from PARP-1, resulting in upregulation of
PARP-1 activity, which supports neuron sur-
vival. After dissociation from PARP-1, KIF4 en-
ters into the cytoplasm from the nucleus and
moves to the distal part of neurites in a micro-
tubule-dependent manner. We suggested that
KIF4 controls the activity-dependent survival
of postmitotic neurons by regulating PARP-1
activity in brain development.
INTRODUCTION
The kinesin superfamily (KIF) of proteins are microtubule-
based motor proteins specialized in the transport of
membrane organelles, protein complexes, and mRNAs
(Hirokawa, 1998; Hirokawa and Takemura, 2005). Kinesin
superfamily protein 4 (KIF4), a KIF member classified in
Kinesin-4 in the standardized nomenclature (Lawrence
et al., 2004), is strongly expressed in juvenile tissues in-
cluding differentiated young neurons, where it localizes
in nuclei and growth cones (Aizawa et al., 1992; Sekine
et al., 1994). In growth cones, KIF4 colocalizes with mem-
branous organelles, suggesting its role in vesicle transport
(Sekine et al., 1994; Peretti et al., 2000). On the other hand,several possible KIF4 homologs have been identified:
chromokinesin (chicken; Wang and Adler, 1995), XKLP1
(Xenopus; Vernos et al., 1995), and hKIF4A (human; Oh
et al., 2000; Lee et al., 2001). These homologs are reported
to be mitotic motors implicated in chromosome segre-
gation during mitosis. Thus, the physiological function of
KIF4 is controversial and its role in postmitotic neurons re-
mains obscure.
Here, we demonstrate that KIF4 regulates programmed
cell death of juvenile neurons by interacting directly with
poly (ADP-ribose) polymerase-1 (PARP-1), a nuclear en-
zyme that modifies various nuclear proteins with poly
ADP-ribosylation (Althaus and Richter, 1987; D’Amours
et al., 1999). When activated by DNA damage or biological
signals, PARP-1 maintains cell homeostasis through re-
pairing DNA, controlling the energy balance, and serving
as a transcriptional regulator (Griesenbeck et al., 1999;
Tulin and Spradling, 2003). It is reported that in fetal neu-
rons,membranedepolarization induces activation of PARP-1
via Ca2+ influx into nucleoplasm (Homburg et al., 2000).
Our results demonstrated that PARP-1 activation prevents
neuronal apoptosis, which is regulated byKIF4 in amanner
dependent on membrane depolarization. We suggest that
the control of PARP-1 activity by KIF4 underlies the
activity-dependent neuronal survival that contributes to
the organization of the nervous system via regulating the
number of neurons during brain development.
RESULTS
Mitotic Division Is Normal in Cells Lacking KIF4
Using a gene-targeting strategy, we generated ES cell
clones with disrupted kif4 genes as a tool for investigating
the function of KIF4 (see Figure S1 in the Supplemental
Data available with this article online). Because kif4 gene
is located on sex chromosome X, single homologous re-
combination at the kif4 locus is enough to generate kif4
null (kif4/Y) ES cell clones. Three independent kif4 null
(kif4/Y) clones (1, 2, and 3) were used throughout the
study. Kif4/Y cells did not show any difference in the
shape or size of colonies, compared with wild-type
(kif4+/Y) cells (Figure S2A). To examine the role of KIF4 inCell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc. 371
mitosis, we performed DNA analysis of these cells using
flow cytometry. There was no difference between geno-
types in the distributions of the DNA contents of the cells
(Figure S2B), suggesting that chromosome segregation
and mitotic cell division were intact in the kif4/Y cells.
KIF4 Binds Directly to PARP-1
The nonmotor domain of KIF4 (the tail domain—amino
acids no.1005–1231) is expected to associate with a spe-
cific binding protein (Nakagawa et al., 2000). To identify
proteins binding to KIF4 in 5-day-old mouse brain, the
tail domain of KIF4 fused to GST was prepared as bait
for screening (GST-KIF4 tail in Figure 1Aa). After incuba-
tion of brain homogenates with GST-KIF4 tail beads, the
110 kDa band was specifically eluted with 1.0 M NaCl
buffer (Figure 1Ab, arrow), not only with the GST beads
(Figure 1Ac). In this condition, this was the only band iden-
tified as a possible binding partner for KIF4. Amino acid
sequencing and mass spectrometry revealed that the
110 kDa protein was PARP-1 (data not shown).
KIF4 and PARP-1 were coimmunoprecipitated from cell
lysates using either anti-KIF4 or anti-PARP-1 antibodies,
but not from lysates of kif4/Y cells (Figure 1B). Further-
more, purified recombinant GST-KIF4 tail was demon-
strated to bind to purified PARP-1 (Figure 1C). In this
experiment, about half of the PARP-1 in the reaction buffer
was collected fromGST-KIF4 tail beads, whereas no com-
plex formation was detected from control beads (Fig-
ure 1C). Next, to exclude the possibility that KIF4 and
PARP-1 form a complex through their binding to DNA,
we compared in vitro complex formation between in the
presence and absence of DNA. DNA did not affect com-
plex formation (Figure 1C), and DNA pull-down assays
also revealed that the KIF4 tail domain did not bind to
DNA, whereas PARP-1 did, as previously reported (Fig-
ure 1D). Collectively, we conclude that KIF4 binds to
PARP-1 by direct interaction.
KIF4 Suppresses Enzymatic Activity of PARP-1
To examine the possible effect of KIF4 on PARP-1 enzy-
matic activity, we analyzed in vitro automodification of
PARP-1 with poly (ADP-ribose) (PAR). 32P-NAD labeling
represents the auto-poly ADP-ribosylation of PARP-1
(Figure 2A). The addition of the KIF4 tail domain inhibited
automodification in a dose-dependentmanner (Figure 2A),
indicating that the binding of the KIF4 tail domain sup-
presses PARP-1 activity. Next, to examine the in vivo
interaction of KIF4 with PARP-1, we transfected various
KIF4-GFP constructs into NIH 3T3 cells (Figure 2B). Full
length and headless KIF4-GFP colocalized with native
PARP-1 in the nucleus (Figure 2Bb). However, tailless
KIF4-GFP, which lacks a PARP-1 binding site, localized
not only in the nucleus but also in cytoplasm (Figure 2Bb).
These results suggest that the nuclear localization of KIF4
is mediated by its binding to PARP-1. Next, to examine
functional aspects of the KIF4-PARP-1 interaction,
PARP-1 activation induced by H2O2 treatment was com-
pared among cells transfected with the constructs.372 Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc.PARP-1 activity was quantified by measuring the fluores-
cence intensity of anti-PAR antibody (10H) labeling. Cells
expressed with full-length and headless KIF4-GFP that
contain the PARP-1 binding (tail) domain of KIF4 showed
lower immunoreactivity, whereas the expression of tailless
KIF4-GFP that lacks PARP-1 binding domain did not have
such an effect, suggesting that tail domain is the respon-
sible region in KIF4 to suppress PARP-1 activity in vivo
(Figures 2Bc and 2Bd). Biochemical measurement of the
PARP-1 activities of lysates of the transfected cells also
confirmed the suppression of PARP-1 activity by the over-
expression of the full-length and headless KIF4-GFP con-
structs (Figure 2Be). Treatment with 3-aminobenzamide
(3-AB), a PARP inhibitor, blocked upregulation of PARP-1
Figure 1. KIF4 Binds to PARP-1 with Its Tail Domain
(A) Screening of KIF4 binding protein. (a) Structural view of full length
KIF4 and GST-KIF4 tail fusion proteins. Putative NLS (nuclear localiza-
tion signal, amino acids no. 794–799; Lee et al., 2001) is depicted. (b)
GST pull-down. P110 in 1.0MNaCl-eluents are visualized by Coomas-
sie brilliant blue (arrow). Each lane corresponds to sequential elution
(three times in 1.0 M NaCl buffer and three times in 2.0 M NaCl buffer,
respectively). (c) Negative control using only GST.
(B) Immunoprecipitation of ES cell lysates (a) and fibroblast cell lysates
(b) show that KIF4 and PARP-1 form a complex. Immunoblotting of
lysates is also presented in (a). IgG was used for negative control ex-
periments in (b).
(C) In vitro binding assay. About a half of the PARP-1 is collected by the
GST-KIF4 tail beads. Various amounts of PARP-1 were loaded in the
left four lanes for a comparison. The presence of DNA did not affect
the results.
(D) DNA pull-down using DNA-cellulose. PARP-1 binds to DNA but
GST-KIF4 tail does not. FT: flow through.
Figure 2. Regulation of PARP-1 Enzymatic Activity by KIF4
(A) Effect of KIF4 tail on PARP-1 automodification. 32P-NAD-labeled PARP-1 represents the automodification of PARP-1, which is inhibited by the
addition of GST-KIF4 tail (upper panel). Activated calf-thymus DNA (Scovassi et al., 1984) was added to each sample. Immunoblotting using anti-
PARP-1 and anti-GST antibodies is shown in the middle and lower panels.
(B) Overexpression of deletion mutants. (a) Structure of GFP-fusion proteins. (b) Fluorescent images of transfected cells. Bar = 10 mm. (c) Immuno-
labeling of transfected cells with anti-poly (ADP-ribose) (PAR) antibody after PARP-1 activation by DNA damage. Bar = 10 mm. (d) Measurement of
fluorescence intensities using anti-PAR antibody. A total of 300 transfected cells in three independent experiments were examined. Mean ± SEM is
presented (***p < 0.001; t test). (e) Biochemical measurement of PARP-1 activity of lysates of transfected cells. The transfection efficiency of each
vector was adjusted to about 35%. Each value was calculated from three independent experiments. Mean ± SD is presented (*p < 0.05; t test).
(C) PARP-1 activity of kif4+/Y and kif4/YES cells before and after PARP-1 activation by H2O2-induced DNA damage. Three independent kif4
/Y ES cell
clones were analyzed. Data were collected from five experiments. Mean ± SEM is presented (*p < 0.05; t test).Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc. 373
activity induced by H2O2 treatment, irrespective of the
presence or absence of the transfected constructs (Fig-
ure 2Be). Consistently, PARP-1 activity was upregulated
in kif4/Y ES cells both with and without H2O2 treatment
(Figure 2C). Taken together, we conclude that KIF4 sup-
presses PARP-1 activity through the binding of its tail
domain with PARP-1.
Neurons Lacking KIF4 Are Resistant to Apoptosis
Next, to analyze the role of KIF4 in postmitotic neurons, we
generated kif4+/Y and kif4/Y neurons by in vitro differenti-
ation of ES cells. After an induction of neuronal differenti-
ation, 90 percent of the cells turned into MAP2-positive
neurons in both genotypes (Figure S3A). Further immuno-
cytochemistry showed that these neurons were mainly
glutamate positive, that some were GABA positive (Fig-
ures S4Aa and S4Ab), and that they expressed NMDA-re-
ceptor (subunit 2B; Figure S4Ba and S4Bb). Importantly,
they did not express choline acetyltransferase (ChAT;
Figure S4C). These results indicate that they have a prop-
erty typical of neurons in the central nervous system, not
of ones in peripheral nervous system. Between geno-
types, there was no difference in cell morphology, expres-
sion of various neuronal markers, and in axon-dendrite
polarity, suggesting that KIF4 is not essential for neuronal
differentiation (Figures S3B and S4).
PARP-1 has been implicated in the mechanism of neu-
ronal cell death (Nicoletti and Stella, 2003). Although a
pathological overactivation of PARP-1 leads to cell death
due to an energy deficit (Ha and Snyder, 2000), it has been
suggested that a physiological activation of PARP-1 could
protect neurons from apoptosis (Nicoletti and Stella,
2003). In this context, we compared survival between
the genotypes of MAP2-positive cells kept in culture me-
dium deprived of trophic factors (Weller et al., 1997; Ikeu-
chi et al., 1998; Putcha et al., 2002). The survival rate of
MAP2-positive neurons was much higher in kif4/Y cell
cultures than in kif4+/Y cell cultures after 6 days deprivation
of trophic factors (Figures 3A and S5). Nuclear staining us-
ing 40,6-diamidino-2-phenylindole, dihydrochloride (DAPI)
revealed a lower rate of apoptosis in kif4/Y neurons to be
responsible for the difference (Figure 3B). In the presence
of a PARP-1 inhibitor (3-AB or 1,5-isoquinolinediol [DHIQ]),
the percentage of apoptotic cell death of kif4/Y neurons
was increased to reach the level of kif4+/Y neurons (Figures
3A and 3B), indicating that the antiapoptotic resistance of
kif4/Y neurons depends on PARP-1 activity.
Next, we examined whether two well-known antiapo-
ptotic pathways are related to PARP-1 activity. One is me-
diated by neuronal activity (Gallo et al., 1992; Franklin and
Johnson, 1992) and the other by neurotrophic factors (Fer-
rari et al., 1989; Yuan and Yankner, 2000). The survival of
kif4+/Y neurons increased to the level of kif4/Y neurons,
both by membrane depolarization induced by high potas-
sium stimulation and by the addition of trophic factors
(NGF + bFGF) into the medium (Figures 3A and 3B). The
antiapoptotic effect of the membrane depolarization was
blocked by PARP-1 inhibitors, but that of the trophic fac-374 Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc.tors was not, in both kif4+/Y and kif4/Y neurons (Figures
3A and 3B, respectively). These results suggest that
PARP-1 activation is specifically related to the antiapo-
ptotic pathway mediated by the depolarization of the
membrane potentials of young neurons. In parallel with
these experiments, we measured PARP-1 activity in
kif4+/Y and in kif4Y neurons before and after high potas-
sium stimulation. In the kif4/Y neurons, the high potas-
sium treatment increased PARP-1 activity (Figures 3C
and 3D). In contrast, PARP-1 activity in the kif4/Y neurons
was about 2-fold of that in kif4+/Y neurons before stimula-
tion and was relatively unchanged after high potassium
stimulation (Figures 3C and 3D). Taken together, we con-
clude that a lack of KIF4 results in the upregulation of
PARP-1 activity and suggest that KIF4 controls neuronal
cell survival by regulating PARP-1 activity.
KIF4/PARP-1 Complex Regulates Neuronal
Cell Survival
To confirm the possible role of the KIF4/PARP-1 complex
in support of neuronal survival, as suggested by experi-
ments using ES cell-derived neurons, we applied an
RNA interference (RNAi) knockdown approach to a pri-
mary culture of cerebellar granule cells (CGCs), a stan-
dardized model to study mechanisms of neuronal survival
in vitro (Franklin and Johnson, 1992). High potassium treat-
ment on these neurons activated PARP-1 (Figure S6Da) in
a time-dependent manner (Figure S6Db) and supported
cell survival by preventing apoptosis as described previ-
ously (Lin et al., 1997; Weller et al., 1997). This neuropro-
tective effect was blocked by a PARP inhibitor DHIQ (Fig-
ures S6A, S6B, and S6C), and prevention of cell death by
trophic factors was not affected by the PARP inhibitor
(Figures S6A, S6B, and S6C), as observed in neurons dif-
ferentiated from ES cells.
A short interfering RNA (siRNA; 2388–2412) silenced
PARP-1 in CGCs at 2.5 days after transfection (Figures
4A and 4B), whereas scrambled siRNA or noneffective
siRNA (762–786) did not (Figure 4B). Specifically, in cells
treated with siRNA (2388–2412), high potassium treat-
ment failed to protect them from apoptotic cell death after
removal of trophic factors (Figures 4C and 4D), resulting in
a decreased number of live cells (Figures S7A and S7B).
The effect of neurotrophic factors in support of cell sur-
vival was unaffected by knockdown of PARP-1 (Figures
4C, 4D, and S7).
Next, we knocked down KIF4 in CGCs by siRNA (2509–
2533; Figure 4E). Treatment with siRNA (2509–2533), as
well with KCl, increased nuclear labeling with anti-PAR
antibody, demonstrating that PARP-1 was activated in
CGCs (Figures 4F and 4H). Scrambled siRNA did not acti-
vate PARP-1 (Figures 4F and 4H). We monitored cell sur-
vival under the siRNA treatment. SiRNA (2509–2533) in-
creased the number of live cells as well as did KCl
stimulation (Figures 4G and 4I). This effect was sensitive
to DHIQ (Figure 4J). In contrast, cell survival supported
by trophic factors was not sensitive to DHIQ (Figure 4J).
Figure 3. Neuronal Cell Death after Removal of Trophic Factors
(A) Phase contrast images and MAP2 immunolabeling of neurons at 1 and 6 days after removal of trophic factors. Bars = 20 mm.
(B) Percentage of apoptotic cells. Two days after deprivation of trophic factors with various stimuli as denoted at the bottom of the graph, the numbers
of cells with condensed chromatin (shown in the upper panels; bars = 5 mm) per 1000 cells were counted. Three independent kif4/Y clones were
analyzed. Values (mean ± SD) were calculated from three experiments.
(C and D) PARP-1 activity of kif4+/Y and kif4/Y neurons.
(C) PARP-1 activity of cell lysates collected 1 day after deprivation of trophic factors. After treatment with 50 mM KCl for 5min, the PARP-1 activity of
kif4+/Y cell lysates significantly increases (*p < 0.05; t test). In contrast, the PARP-1 activity of kif4/Y neuronswas significantly higher than that of kif4+/Y
before stimulation (*p < 0.05; t test), and is unchanged by KCl treatment. Addition of 3-AB suppresses PARP-1 activity. Mean ± SD is presented. Data
were accumulated from five independent experiments.
(D) Immunolabeling of MAP2-positive cells with anti-PAR antibody before and after treatment with 50 mM KCl for 5 min. Fluorescence intensities of
poly (ADP-ribose) labeling are higher in kif4/Y cells than in kif4+/Y cells before treatment with KCl (arrowheads). Bars = 10 mm.Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc. 375
Figure 4. Knockdown by RNAi
(A–D) Knockdown of PARP-1.
(A) Immunostaining of CGCs at 2.5 days after the transfection of siRNAs is denoted in the panels. Control in (a) means a condition without siRNA. The
percentages of PARP-1-positive cells are denoted at the bottom of the panels. Values (mean ± SD) were calculated from three experiments. The dif-
ferences between (a) and (b) and between (b) and (c) are statistically significant (p < 0.001; t test). Bars = 20 mm.
(B) Immunoblotting of lysates. Values denoted at the bottom are the relative intensity of PARP-1 immunoreactivity calculated from three independent
experiments. (*p < 0.05; t test).
(C) DAPI-staining of CGCs transfected with siRNAs. At day 2 after transfection, trophic factors were removed and cells kept in the conditions denoted
at the bottom of panels for 4 days. Apoptotic cells are indicated by arrowheads. Bars = 20 mm.376 Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc.
Taken together, PARP-1 activation is an essential step
in the pathway for neuronal survival induced bymembrane
depolarization, and this activation is negatively regulated
by KIF4.
Support for Cell Survival Mediated by the
KIF4/PARP-1 Complex Depends on Ca2+ Influx
through the Voltage-Sensitive Ca2+ Channel
Next, we investigated calcium signaling in kif4+/Y and in
kif4/Y cells. KCl-induced membrane depolarization trig-
gers an influx of Ca2+ into cytoplasm and nuclei through
the L-type voltage-sensitive calcium channel (VSCC; Har-
dingham et al., 1998), and the nuclear calcium signal acti-
vates PARP-1 (Homburg et al., 2000). In both kif4+/Y and in
kif4/Y neurons, high potassium stimulation induces cyto-
plasmic and nuclear Ca2+ elevation (Figure 5A). When
Ca2+ influxwas blocked by nicardipine, a selective blocker
for VSCC, high potassium treatment failed to support
kif4+/Y cell survival (Figures 5Ba and 5Bb). On the other
hand, survival of kif4/Y cells stimulated by KCl was not af-
fected by nicardipine treatment (Figures 5Ba and 5Bb).
These observations indicated that Ca2+ influx is required
for activity-dependent cell survival in kif4+/Y neurons and
that kif4/Y neurons are resistant to apoptosis even in
the absence of an elevated Ca2+ level, possibly because
of the persistent elevation of PARP-1 activity. In other
words, regulation of PARP-1 activity by KIF4 is situated
in the downstream of neuronal nuclear calcium influx.
KIF4 Is Dissociated from PARP-1
after Membrane Depolarization
Next, we focused on a possible change in the KIF4-
PARP-1 interaction after membrane depolarization.
Since a recent report has shown that membrane depolar-
ization induces the automodification of PARP-1 by poly
ADP-ribosylation through the influx of Ca2+ into nucleo-
plasm (Homburg et al., 2000), we first examined the effect
of PARP-1 automodification on the binding of PARP-1 to
KIF4 in vitro. AutomodifiedPARP-1did not bind to theKIF4-
tail (Figure 5C). Next, we compared the binding of KIF4 to
PARP-1 before and after KCl stimulation in vivo. High
potassium stimulation decreased the amount of KIF4
immunoprecipitated by the PARP-1 antibody (Figure 5D).
Addition of a calcium chelator O,O0-Bis(2-aminophenyl)
ethyleneglycol-N,N,N0,N0-tetraacetic acid, tetraacetoxy-
methyl ester (BAPTA-AM) into the culturemediumblockedthe decrease (Figure 5D), indicating Ca2+ elevation is nec-
essary for KIF4-PARP-1 dissociation. Along with this, au-
tomodified PARP-1 increased after KCl stimulation, which
was inhibited by the PARP-1 inhibitor DHIQ (Figure 5E).
These biochemical data demonstrate that KIF4 is dissoci-
ated from automodified PARP-1 after membrane depolar-
ization.
We next monitored for possible changes in the cellular
localization of KIF4 after KCl stimulation. Before stimula-
tion, KIF4 is dominantly localized in the nucleus (Fig-
ure 5Fa). In contrast, after cells were treated with high
potassium for 30 min, a considerable immunoreactivity
of KIF4 was observed in neurites (Figures 5Fb and S8).
This altered localization of KIF4 was blocked by the addi-
tion of BAPTA-AM (Figure 5Fc and S8) or the PARP-1
inhibitor DHIQ (Figures 5Fd and S8), indicating that the
localization depends on Ca2+ and PARP-1 activity. The lo-
calization of PARP-1 did not change after depolarization
(Figures 5Fe and 5Ff). The redistribution of KIF4 was
also blocked by nocodazol, amicrotubule-depolymerizing
agent (Figures 5Ga, 5Gb, and S8), accompanied by an in-
termittent disruption of microtubules in neurites (Figures
5Gc and 5Gd) without affecting cell viability revealed by
5-chloromethylfluorescein diacetate (CMFDA), a fluores-
cent tracer that diffuse through the membranes of live
cells (Figures 5Ga and 5Gb). Together, these data suggest
that a microtubule-dependent motility of KIF4 underlies its
translocation after depolarization. This activity-dependent
translocation of KIF4 into cytoplasm and its inhibition
by DHIQ and BAPTA-AM was also clearly observed in
CGCs (Figure S9).
CaMKII Plays Pivotal Roles
in the KIF4/PARP-1 Pathway
These events, nuclear Ca2+ elevation, activation of
PARP-1, and translocation of KIF4 to cytoplasm, were re-
produced by an alternative method of neuronal activation,
electrical field stimulation to CGCs. With 50 Hz pulse stim-
uli, nuclear poly ADP-ribosylation accompanied with cal-
cium elevation was induced (Figures 6A, 6Ba, and 6Bb)
and translocation of KIF4 into cytoplasm was increased
(Figures 6Ca and 6Cb). Using this system, we addressed
the possible involvement of calcium-calmodulin kinase II
(CaMKII) in the regulation of PARP-1 activity, inspired
by a recent report showing that PARP-1 is activated by
CaMKII phosphorylation (Ju et al., 2004). Both processes,(D) Percentage of apoptotic cells. Values (mean ± SD) were calculated from three independent experiments. (**p < 0.01; t test).
(E–J) Knockdown of KIF4.
(E) Immunoblotting of lysates. Values denoted at the bottom are the relative intensity of KIF4 immunoreactivity calculated from three independent
experiments. (*p < 0.05; t test).
(F) Immunolabeling by anti-PAR antibody for CGCs transfected with siRNAdenoted at the top of each panel and subjected to various stimuli for 10min
denoted at the bottom. Control means without siRNA. White line circles indicate nuclei. Bars = 20 mm.
(G) CMFDA labeling and phase-contrast images of CGCs transfected with siRNAs targeted for KIF4. At 1 day after transfection, survival assay was
started and cells were kept under the various conditions denoted at the bottom of the panels for 7 days. Bars = 20 mm.
(H) Statistical analysis of PAR-positive cells in nuclei after various stimuli denoted at the bottom of panel. Nuclear positive cells per 200 cells were
counted for each experiment. Mean ± SD calculated from three experiments is presented. (**p < 0.01; t test).
(I and J) Percentages of living cells cultured under the various conditions for 7 days are denoted at the bottom of the panels. Values (mean ± SD) were
calculated from three independent experiments. (*p < 0.05 and **p < 0.01; t test).Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc. 377
Figure 5. KIF4 Is Dissociated from
PARP-1 and Moves to Neurites after
Membrane Depolarization
(A) Before and after incubation with 25 mM KCl
for 15 min, both kif4+/Y and kif4/Y neurons
were labeled with 5 mM Rhod2-AM, a calcium-
sensitive fluorescent dye. White line circles
show the area of nuclei. Bars = 10 mm.
(B) Effect of VSCC blocker nicardipine (Nic) on
KCl-dependent survival of MAP2-positive cells.
(a) Survival of MAP2-positive cells. (b) Percent-
ages of apoptotic cells (mean ± SD) were cal-
culated from three experiments using DAPI
staining (*p < 0.05; t test).
(C–E) Activity-dependent dissociation of KIF4
from PARP-1.
(C) Effect of the automodification of PARP-1 on
its binding to KIF4. Activated calf-thymus DNA
(Scovassi et al., 1984) was added to each sam-
ple. (a) PARP inhibitors (DPQ and DHIQ) inhibit
the 32-P-NAD-labeling of PARP-1 (upper
panel). Immunoblotting using anti-PARP-1 an-
tibody (lower panel). (b) Binding of PARP-1
with GST-KIF4 tail. Automodified PARP-1
does not bind to KIF4 tail.
(D) (a) Interaction between KIF4 and PARP-1 in
depolarized neurons. After depolarization in the
presence or absence of BAPTA-AM, lysates
were collected and immunoprecipitation per-
formed using anti-PARP-1 antibody. (b) The
KIF4/PARP-1 ratio of the intensity of the immu-
noblots (mean ± SD; *p < 0.05; t test).
(E) Increased automodification of PARP-1 in
depolarized neurons. 32-P-NAD-labeled PARP-1
is immunoprecipitated.
(F) Immunolabeling of neurons with KIF4 (a–d)
and PARP-1 (e and f) antibodies before and
after depolarization. (a) Cells before depolar-
ization. (b) Cells treatedwith 50mMKCl. Immu-
noreactivity of KIF4 in neurites is indicated by
arrowheads. (c) Cells treated with 50 mM
KCl + 6 mM BAPTA-AM (a calcium chelator).
(d) Cells treated with 50 mM KCl + 50 mM DHIQ. In (c) and (d), redistribution of KIF4 was inhibited. (e and f) Immunolabeling of neurons before (e)
and after (f) depolarization using anti-PARP-1 antibody.
(G) (a and b) Nocodazol (Noc)-treated cells were incubated with 50 mM KCl for 25 min and immunolabeled by anti-KIF4 antibody. Nocodazol treat-
ment decreases KIF4 immunoreactivity in neurites (arrowheads in [b]). CMFDA labeling in (a) and (b) demonstrates that nocodazol treatment did not
affect cell viabilities. (c and d) Effect of nocodazol. Neurons treated with 2.5 mM nocodazol for 1 hr show an intermittent disruption of microtubules in
neurites (d, arrowheads).PARP-1 activation and KIF4 translocation in CGCs after
field stimulation (Figures 6Bb, 6Bc, 6Cb, and 6Cc) or
high potassium stimulation (data not shown), were
blocked by CaMKII inhibitor KN-62. When activated by
membrane depolarization, PARP-1 was phosphorylated
(Figure 6Da). This phosphorylation, PARP-1 automodifica-
tion, and PARP-1/KIF4 dissociation are sensitive to KN-62
(Figures 6Da, 6Db, and 6Dc), suggesting that these events
are under the control of CaMKII.
Overexpression of Headless KIF4 Promotes
Neuronal Cell Death in Developing Brain
Finally, to confirm the role of KIF4 in the developingmouse
brain, we overexpressed kif4 vectors by in utero electro-
poration. For an assessment of the function of PARP-1378 Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc.binding (tail) domain in controlling neuronal cell death,
we prepared two types of vectors: headless and tailless
kif4 (Figure 7A). Each vector was designed to express trun-
cated KIF4 and GFP in a bicistronic fashion mediated by
internal ribosome entry site (IRES; Figure 7A). When trans-
fected into cultured cells, headless kif4 blocked PARP-1
activation induced by H2O2, but tailless kif4 did not, as de-
scribed above (Figure 2Bc). At 3 days after in utero electro-
poration, the GFP signal was detected in neurons situated
in the hippocampal CA1 field (Figure 7B). Enhancement in
immunoreactivity against KIF4 was confirmed in GFP-
positive neurons (Figure 7C). We compared numbers of
GFP-positive neurons per area between headless- and
tailless- transfected brain sections. At 3 days after electro-
poration, there was no difference (Figures 7D and 7E),
Figure 6. CaMKII Mediates Depolariza-
tion-Dependent PARP-1 Activation and
Dissociationof theKIF4/PARP-1Complex
(A–C) Electrical stimulation applied to CGCs.
(A) Calcium imaging using fluo-4 AM for CGCs
before and after stimulation is denoted at the
top of each panel. Bars = 10 mm.
(B) Immunolabeling by anti-PAR antibody after
subjecting to the stimuli denoted at the top of
each panel. Bars = 10 mm. Values mean per-
centages of nuclear positive cells per 200 cells.
Mean ± SD calculated from three experiments
is presented. (a and b: **p < 0.01; b and c:
**p < 0.01; t test).
(C) Cellular localization of KIF4 after field stim-
ulation. KIF4 was immunolabeled after subject-
ing to the various stimuli denoted at the top of
each panel. The elevated immunoreactivity of
KIF4 in neurites is indicated by arrowheads.
Values mean percentages (mean ± SD) of cells
with illuminated neurites per 200 cells calcu-
lated from three experiments. (a and b: **p <
0.01; b and c: **p < 0.01; t test). Bars = 10 mm.
(D) CaMKII-dependent phosphorylation of
PARP-1 in CGCs. (a) Labeling of PARP-1 with
[32P]-orthophosphate before and after depolar-
ization (upper panel). The phosphorylation of
PARP-1 was blocked by KN-62. Bottom panel
shows immunoblotting of immunoprecipitates
using anti-PARP-1 antibody. (b) Automodifica-
tion of PARP-1. Cells were subjected to the
various stimuli denoted at the top of the panel,
and lysates were immunoprecipitated using
anti-PAR antibody and immunoblotted with
anti-PARP-1 antibody. (c) KIF4 is dissociated
from PARP-1 after KCl treatment. KN-62
blocks this dissociation.whereas at 6–8 days after, the numbers of GFP-positive
neurons in sections transfected with the headless kif4
gene were lower than in ones with the tailless kif4 gene
(Figures 7D and 7E), suggesting the effect of the KIF4 tail
domain to enhance cell death. We examined the morphol-
ogy of GFP-positive neurons in detail at 8 days after elec-
troporation and found that the neurons transfected with
headless kif4 gene lacked neurites and showed con-
densed nuclear chromatin (Figure 7Fa), whereas the mor-
phology of neurons transfected with tailless kif4 gene
was intact (Figure 7Fb). These results indicate that overex-
pression of the KIF4 tail domain enhanced cell death in the
developing brain possibly by the inhibition of PARP-1
activity.
DISCUSSION
The Role of KIF4 in Brain Development
Juvenile neurons die in a physiological process during de-
velopment that, in cooperation with the regulation of cell
proliferation, contributes to the control of cell numbers.
Programmed cell death plays a major part in this process
(Yuan and Yankner, 2000) and is regulated by neuronal
activity and successive Ca2+ signaling. We found thatthe regulating mechanism for this activity-dependent pro-
grammed cell death is mediated by the KIF4/PARP-1
complex, a combination of a kinesin superfamily protein
and a nuclear enzyme.
In spite of its abundant expression, little is known as
regards KIF4 and its role in postmitotic neurons (Sekine
et al., 1994). Through biochemical, cell-biological, and
molecular-genetic approaches, we demonstrated an un-
expected role for KIF4 in the control of activity-dependent
cell survival of juvenile neurons. Our data suggest the con-
cept wherein the C terminus of the kinesin superfamily
protein, which is regarded as a cargo binding domain in
other KIFs (Hirokawa and Takemura, 2005), serves as a
controlling module for the enzymatic activity of its binding
protein. This might be an example of ‘‘domain shuffling’’
during protein evolution, where domains with different
functions are accidentally combined together to generate
a variety of new molecules.
The results suggest a model of the sequential events in
the control of activity-dependent cell survival that are pre-
sented schematically in Figure 7G. (1) In a steady state,
KIF4 binds to PARP-1 and suppresses PARP-1 activity.
Cells are then prone to apoptotic death. (2) Membrane de-
polarization triggers Ca2+ influx into nucleoplasm via theCell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc. 379
Figure 7. Overexpression of Headless KIF4 Promotes Neuronal Cell Death in Developing Brain
(A–F) In utero electroporation of KIF4 expression vectors.
(A) Construction of the expression vectors. Headless or tailless kif4 genes were inserted in the downstream of the CAG promoter for bicistronic coex-
pression with GFP. MCS: multicloning sites.
(B) A typical view of GFP expression in cerebrum transfected with the headless kif4 construct. Coronal section of whole brain at 3 days after electro-
poration (postnatal day 1) is shown. Bars = 100 mm.
(C) Coexpression of GFP with KIF4. KIF4 is illuminated by immunolabeling with anti-KIF4 polyclonal antibody. Bars = 10 mm.
(D) GFP-positive cells in brain sections transfected with headless kif4 (a and b) or tailless kif4 (c and d). Sections photographed at 3 (a and c) and 8
(b and d) days after electroporation are shown. Bars = 10 mm.
(E) Statistical analysis. An area of about 3.8mm2 of each section was examined and themean number (mean ±SD) of GFP-positive cells per 0.21mm2
(corresponding to a visual field of 20 objective) are shown. To calculate each point on the graph, 18 sections obtained from two independent electro-
poration were examined. ***p < 0.001; t test.
(F) Cellular morphology of GFP-positive neurons. GFP signal (left panels), DNA labeling (middle panel), and merged (right panel) of sections trans-
fected with headless (a) and tailless (b) kif4 genes. Arrowheads show nucleus with condensed chromatin. Values at the bottom of the middle panels
mean percentages (mean ± SD) of GFP-positive cells with condensed chromatin. Forty cells observed in 18 sections (obtained from two electropo-
rations) were used to calculate each value. The difference between the values was statistically significant, **p < 0.01; t test). Bars = 10 mm.380 Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc.
IP3 receptor localized on nuclear membrane. Elevated
Ca2+ makes a complex with calmodulin (CaM) and acti-
vates CaMKII, which phosphorylates PARP-1. (3) These
events trigger automodification of PARP-1 (Homburg
et al., 2000) . (4) KIF4 is dissociated from poly ADP-ribosy-
lated PARP-1 and moves into neurites, where it can trans-
port some cargoes to the distal part of neurites in a micro-
tubule-dependent manner. These observations clearly
show a role for KIF4 as amolecular motor in cytoplasm; in-
deed, a previous study reported that KIF4 is involved in the
transport of L1, an adhesion molecule required for axon
formation (Peretti et al., 2000). Possibly, KIF4 may trans-
port cargoes required for neuronal development, such
as L1, after dissociation from PARP-1 in an activity-
dependent manner (Figure 7G). Considering the accumu-
lated evidence, an intriguing possibility arises that KIF4
has a dual role in the nucleus and cytoplasm of neurons
and contributes to brain development, although further
characterization of the cargo of KIF4 is still necessary.
As for the function of KIF4 in proliferating cells, several
candidates for a KIF4 homolog have been identified and
implicated in mitosis (Wang and Adler, 1995; Vernos
et al., 1995; Oh et al., 2000; Lee et al., 2001). Contrary to
expectations, ES cells lacking KIF4 divided normally,
showing that at least in murine ES cells KIF4 was not es-
sential for mitotic cell division (Figure S2). This could be
because there is a redundancy among KIF4 and some
other murine KIFs in mitosis or because the candidates
are not true homologs of murine KIF4 but rather variants
with different functions from that of murine KIF4. Support-
ing this view, the homology of the tail domain is signifi-
cantly low among murine KIF4, chromokinesin, XKLP1,
and hKIF4A.
PARP-1 Prevents Apoptosis
PARP-1 is a multifunctional protein that has been impli-
cated in the control of cell death (D’Amours et al., 1999).
In pathological conditions such as brain ischemia or
NMDA receptor-mediated neurotoxicity, an overactiva-
tion of PARP-1 induces cell death through the acute con-
sumption of intracellular energy sources such as ATP and
NAD (Didier et al., 1994; Mandir et al., 2000; Garnier et al.,
2003). It is also well known that PARP-1 is cleaved by cas-
pase-3 in the late stage of apoptosis (Kawahara, et al.,
1998; Gilliams-Francis et al., 2003).
Aside from these findings, recent studies have focused
on PARP-1 activation in physiological condition. In neu-
rons, PARP-1 is activated by a Ca2+-mediated signal
induced by membrane depolarization (Figure 7G; Hom-
burg et al., 2000) and poly ADP-ribosylation mediates
long-termmemory in Aplysia sensitized by repetitive stim-
uli (Cohen-Armon et al., 2004). In our study, knock-down
experiments using RNAi (Figure 4) and pharmacologicalblocking (Figures 3 and S5) of PARP-1 activity directly re-
vealed another important aspect of PARP-1’s physiologi-
cal roles: its activation protects juvenile neurons from ap-
optotic cell death. It is notable that bothmemory formation
and neuroprotection require Ca2 influx induced by mem-
brane depolarization, raising the possibility that both pro-
cesses share the same mechanism, although details of
how membrane depolarization protects juvenile neurons
from apoptosis is not fully understood (Franklin and John-
son, 1992; Kocsis et al., 1994;Weller et al., 1997; Lin et al.,
1997; Hardingham et al., 1998; Malviya and Rogue, 1998).
So, how does PARP-1 participate in this neuroprotec-
tive pathway? One possibility is that it induces the expres-
sion of antiapoptotic genes, acting as a coactivator of var-
ious transcription factors (Kraus and Lis, 2003), such as
nuclear factor kB (NF-kB). In support of this view, previous
studies have reported that NF-kB is activated by mem-
brane depolarization (Kaltschmidt et al., 1995) and also
by PARP-1 (Chang and Alvarez-Gonzalez, 2001; Chiarugi
and Moskowitz, 2003) and that it supports the survival of
neurons by inducing expressions of several antiapoptotic
genes such as inhibitors of apoptosis protein 1 (c-IAP-1),
c-IAP-2, and Bcl-XL (Bhakar et al., 2002).
In the context of transcriptional regulation, activated
PARP-1 is reported to regulate neurogenic gene expres-
sion under the control of calcium signaling (Ju et al.,
2004). It is noteworthy that CaMKII plays a critical part in
this process, as it does in the neuroprotective pathway
mediated by the KIF4/PARP-1 complex. On the other
hand, KIF17b, another kinesin-related protein, is reported
to participate in transcriptional regulation through inter-
acting with a transcriptional coactivator in male germ cells
(Macho et al., 2002). Considering the possibility that KIF4
also regulates gene expression related to apoptosis via its
binding with PARP-1 (Figure 7G), detection of genes with
their expression under the control of the KIF4-PARP-1 in-
teraction is an important subject for future research.
EXPERIMENTAL PROCEDURES
Production of Recombinant Protein and GST Pull-Down
GST-KIF4 tail (amino acid no. 1005–1231) was produced by an E. coli
BL21 RIL expression system (Novagen) using standard techniques
(Kaelin et al., 1992). For GST pull-down, brain high-speed supernatant
from 5-day-old mice was applied to KIF4 tail conjugated glutathione
beads (Pharmacia). After an overnight incubation at 4ºC, eluents
were collected sequentially by adding NaCl (1.0, 2.0 M) buffer. P110
was excised from the gel and subjected to peptide sequencing (Apro-
science Corp.) and mass spectrometry (Genomic Solutions, Inc.).
In Vitro Protein Binding Assay
Six micrograms of GST-KIF4 tail conjugated with Sepharose beads
was incubated with 2 mg of partially purified PARP (Biomol. Inc) in a re-
action buffer (20 mM Tris-HCl [pH 7.4], 0.15 M NaCl, 100 mg/ml BSA,
protease inhibitors [Roche]) at 4ºC for 6 hr in the presence or absence(G) Schematic model of the involvement of KIF4 in the regulation of the survival of developing neurons. (1) KIF4 binds to PARP-1 and inhibits PARP-1
activity. (2) After membrane depolarization, elevated Ca2+ activates CaMKII, which phosphorylates PARP-1. (3) PARP-1 is automodificated (Homburg
et al., 2000). (4) KIF4 is dissociated from poly ADP-ribosylated PARP-1 andmoves into neurites. Upregulated PARP-1 activity promotes expression of
genes and modifies nuclear proteins to support cell survival.Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc. 381
of a final 50 mg/ml calf thymus DNA (Sigma) and analyzed by immuno-
blotting. To examine DNA-protein binding, 7 mg of purifiedGST-KIF4 or
1 mg of purified PARP was incubated in the reaction buffer described
above with 25 ml of 2 mg/ml DNA-cellulose (Pharmacia) at 4ºC for
6 hr and analyzed by immunoblotting.
Measurement of PARP-1 Activity
Biochemical measurement of PARP-1 activity was performed accord-
ing to a reported method (Schraufsta¨tter et al., 1988) as follows: 2 ml of
2 mM nicotinamide-adenine dinucleotide, [adnine-2,8-3H] (NEN) was
added to the cell suspension and incubated at 25ºC for 20 min. The ra-
dioactivity of the acid-insoluble material collected as precipitates was
counted using a liquid scintillation counter.
Poly ADP-Ribosylation of PARP-1
Four microliters of 10 mM 32P-NAD was added to the neuronal cell cul-
ture and incubated for 30 min. KCl (50 mM) was added and further
incubated for 30 min. Lysate was then collected and applied for anti-
PARP-1 immunoprecipitation. The radioactivity of 32P-NAD-labeled
PARP-1 was detected by autoradiography.
RNAi
siRNA (stealth RNA) directed against PARP-1 and KIF4 were pur-
chased from Invitrogen. CGCs were transfected with siRNA using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions. The nucleotide sequences of the siRNA were as follows:
siRNA targeted for PARP-1—siRNA (762–786), 50-AAGCUUACUAUA
CUUAUCUGUCUCC-30; siRNA (2388–2412), 50-AAGACUAUAGGC
CACCUCGAUGUCC-30; scrambled siRNA (2388–2412), 50-AAGGUAU
AUCCGGACCACAGCUUCC-30; siRNA targeted for KIF4—siRNA
(2509–2533), 50-TTACGACGGCGCTCACTCAACTTGG-30; scrambled
siRNA (2509–2533), 50-TTACTGCGCAGCGCTCTCAAACTGG-30.
Survival Assay of CGCs
At day 1 after plating (8  104 cells/cm2), the medium was changed to
mN3 medium without NGF and bFGF. According to each of the exper-
imental conditions, cells were maintained in the presence or absence
of KCl (25mM), DHIQ (50 mM), or trophic factors (NGF [100 ng/ml] + ba-
sic FGF [5 ng/ml]). After 6 days, cells were labeled with 2.5 mMCMFDA
(Molecular Probes), and numbers and densities of CMFDA-positive
cells were calculated. DAPI staining was performed at day 5 to calcu-
late the number and density of apoptotic cells. For RNAi experiments,
CGCs (8 104 cells/cm2 for PARP-1 knockdown, 4 104 cells/cm2 for
KIF4 knockdown) transfected with the siRNAs were kept for two days
in N3FL medium containing bFGF and NGF, and then survival assay
was started by the removal of trophic factors.
Field Stimulation
The method for electrical stimulation of CGCs was essentially that de-
scribed by Ozaki et al. (2004). In brief, CGCs were subjected to electri-
cal stimulation using dish electrodes (custom designed by Unique
Medical Co. Ltd). Pulses were generated by a stimulator (Master-8,
A.M.P. Instruments Ltd or SEN-7203, Nihon Kohden Ltd). After rectan-
gular pulses of alternating polarity (0.2 ms width and 0.5–5 V intensity)
at 50 Hz were applied to CGCs in mN3 medium, CGCs were immuno-
labeled using anti-PAR or anti-KIF4 antibody.
Phosphorylation Assay
CGCs grown in mN3 medium were supplemented with phosphate-free
DMEM (Gibco) for 1.5 hr and labeled with 32P-orthophosphate (Amer-
sham Biosciences, 10 mCi/ml) for 1.5 hr. CGCs were then incubated
with 50 mM KCl in the presence or absence of 5 mMKN-62 (Seikagaku
Corporation). Lysate was collected using TritonX-100 and 50 nM oka-
daic acid (Sigma) containing buffer and subjected to immunoprecipita-
tion using anti-PARP-1 antibody. Immunoprecipitates were electro-
phoresed and the gel exposed to an imaging plate.382 Cell 125, 371–383, April 21, 2006 ª2006 Elsevier Inc.In Utero Electroporation
The method for in utero electroporation was essentially that described
by Tabata and Nakajima [2001]. Uterine horns of pregnant mice at E16
were exposed, and 1–2 mg of plasmid solution was injected into the lat-
eral ventricle with a glass micropipette. The embryo in the uterus was
placed between the tweezers-type electrode, which has 5 mm diame-
ter disc electrodes at the tip (CUY650-5; Tokiwa Science). Electrical
pulses (40 V and later; 50 ms) were charged five times at intervals of
950 ms with an electroporator (ECM830; BTX, a division of Gene-
tronics, Inc.). Uterine horns were then placed back into the abdominal
cavity to allow the embryos to continue normal development.
Supplemental Data
Supplemental Data include nine figures and Supplemental Experimen-
tal Procedures and can be found with this article online at http://www.
cell.com/cgi/content/full/125/2/371/DC1/.
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